Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The journals of gerontology. Series A, Biological sciences and medical sciences

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/GERONA/60.11.1451PMID 16339333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Testosterone therapy in glucocorticoid-treated men

  2006cited by this paper
• Testosterone and aging : clinical research directions

  2004influential reference
• AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

  2004cited by this paper
• Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone.

  2004cited by this paper
• Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss.

  2004cited by this paper
• AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

  2003cited by this paper
• Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

  2003cited by this paper
• Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.

  2003cited by this paper
• Differential anabolic effects of testosterone and amino acid feeding in older men.

  2003cited by this paper
• Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.

  2003cited by this paper
• Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

  2003cited by this paper
• Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men.

  2002cited by this paper
• Effects of transdermal testosterone on lipids and vascular reactivity in older men with low bioavailable testosterone levels.

  2002cited by this paper
• Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.

  2002cited by this paper
• Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.

  2002cited by this paper
• Testosterone supplementation in older men: a rational idea whose time has not yet come.

  2001cited by this paper
• [Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. A randomized, double-blind, placebo-controlled study].

  2001influential reference
• Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age.

  2001cited by this paper
• Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.

  2001cited by this paper
• Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial.

  2001cited by this paper
• Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age.

  1999cited by this paper
• Effect of testosterone treatment on bone mineral density in men over 65 years of age.

  1999cited by this paper
• Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

  1997cited by this paper
• A randomized trial of testosterone therapy in males with rheumatoid arthritis.

  1996cited by this paper
• Polycythemia as a Complication of Testosterone Replacement Therapy in Nursing Home Men with Low Testosterone Levels

  1995cited by this paper
• Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study

  1993cited by this paper
• Effects of testosterone supplementation in the aging male.

  1992cited by this paper
• The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.

  1992cited by this paper

• Glucocorticoid-induced muscle weakness in ECOPD: a perspective on mechanisms and emerging pharmacological interventions.

  2026cites this paper
• Thrombotic complications of glucocorticoids and anabolic steroids

  2025cites this paper
• Prevalence and predictive factors of testosterone-induced erythrocytosis: a retrospective single center study

  2025cites this paper
• Effect of estrogen and testosterone on cardiac electrophysiology and atrial fibrillation.

  2025cites this paper
• Neuro-Ophthalmic Presentations of Polycythemia.

  2025cites this paper
• Systolic Subclinical Dysfunction in Anabolic Steroid Users: A Real Life Study

  2025cites this paper
• Sex hormones and gender differences in immune responses and anticancer immunity: a comprehensive review

  2025cites this paper
• Testosterone Replacement Therapy for Testosterone Deficiency in Older Men.

  2025cites this paper
• Testosterone Replacement Therapy in Hypogonadal Men with a Prostate Cancer Diagnosis: A British Society for Sexual Medicine Consensus Statement

  2025cites this paper
• Management of hematocrit levels for testosterone replacement patients, a narrative review.

  2025cites this paper
• Fermented Morinda citrifolia extract improves late-onset hypogonadism in aged rats.

  2025cites this paper
• JAK2 wild-type erythrocytosis: concept, differential diagnosis, diagnostic steps, and treatment approaches.

  2025cites this paper
• Management of Adverse Effects in Testosterone Replacement Therapy

  2025cites this paper
• Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy.

  2024cites this paper
• Testosterone supplementation and stroke in young adults: a review of the literature

  2024cites this paper
• Thrombotic Risk Associated with Gender-Affirming Hormone Therapy.

  2024cites this paper
• Evaluating the impact of pre‐diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone‐related cancers: Surveillance, Epidemiology, and End Results‐Medicare 2007–2015

  2024cites this paper
• Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy

  2024cites this paper
• Male hypogonadism: pathogenesis, diagnosis, and management.

  2024cites this paper
• Prostate Risk and Monitoring During Testosterone Replacement Therapy.

  2024cites this paper
• Improvement in Testosterone Production by Acorus gramineus for the Alleviation of Andropause Symptoms

  2024cites this paper
• Testosterone replacement in men with sexual dysfunction.

  2024cites this paper
• Clomiphene Citrate Treatment as an Alternative Therapeutic Approach for Male Hypogonadism: Mechanisms and Clinical Implications

  2024cites this paper
• Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?

  2024cites this paper
• Incorporating transgender and nonbinary participants in phase 1 clinical drug trials: Current knowledge gaps and considerations

  2024cites this paper
• EMAS position statement: Testosterone replacement therapy in older men.

  2023cites this paper
• Testosterone replacement therapy and vascular thromboembolic events: a systematic review and meta-analysis

  2023cites this paper
• Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies

  2023cites this paper
• IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Affirmation as Male

  2023cites this paper
• Testosterone and aging male, a perspective from a developing country

  2023influential citation
• Effects of 12 Months' Treatment with Testosterone Undecanoate on Markers for Erythropoietic Activity and Safety Aspects in Transgender and Cisgender Hypogonadal Men.

  2023cites this paper
• Determinants and reference values for blood volume and total hemoglobin mass in women and men

  2023cites this paper
• Erythrocytosis in Gender-Affirming Care With Testosterone

  2023cites this paper
• Treating Hypopituitarism in the Over 65s: Review of Clinical Studies

  2023cites this paper
• The Effects of Testosterone Treatment on Cardiovascular Health

  2023cites this paper
• Age-Related Dysfunction in Proteostasis and Cellular Quality Control in the Development of Sarcopenia

  2023cites this paper
• Eight weeks of heavy strength training increases hemoglobin mass and V̇O2peak in well-trained to elite female and male rowers.

  2023cites this paper
• New Horizons: Testosterone or Exercise for Cardiometabolic Health in Older Men

  2023cites this paper
• Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size

  2023cites this paper
• Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men

  2023cites this paper
• Haematological actions of androgens.

  2022cites this paper
• PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network.

  2022cites this paper
• Draft of Russian Clinical Practice Guidelines «Male hypogonadism»

  2022cites this paper
• The Effects of Testosterone Treatment on Cardiovascular Health.

  2022cites this paper
• Testosterone Use in the Perioperative Setting

  2022cites this paper
• Hypogonadism and urologic surgeries: a narrative review

  2022cites this paper
• Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.

  2022cites this paper
• Transmasculine Therapy

  2022cites this paper
• Serum multiple organochlorine pesticides in relation to testosterone concentrations among Chinese men from an infertility clinic.

  2022cites this paper
• Androgenic Steroids Use and Abuse: Past, Present, and Future.

  2022cites this paper
• Anabolic–androgenic steroids: How do they work and what are the risks?

  2022cites this paper
• Testosterontherapie

  2022cites this paper
• The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health

  2022cites this paper
• Testosterone therapy in prostate cancer: is it still a controversy?

  2022cites this paper
• The relationship between serum sex hormone and cardiac echocardiographic findings in healthy men

  2022cites this paper
• Morbidity and mortality in men: Role of androgens.

  2022cites this paper
• Exploring the Role of Testosterone Replacement Therapy in Benign Prostatic Hyperplasia and Prostate Cancer: A Review of Safety

  2022cites this paper
• Antiageing strategies

  2022cites this paper
• The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men

  2022cites this paper
• Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism.

  2022cites this paper
• Ageing male (part 2): Management of functional hypogonadism in older men, a patient-centric holistic approach.

  2022cites this paper
• Cardiovascular phenotype of long‐term anabolic‐androgenic steroid abusers compared with strength‐trained athletes

  2022cites this paper
• Hormonal therapies and venous thrombosis: Considerations for prevention and management

  2022cites this paper
• Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk.

  2021cites this paper
• Effects of Long-term Testosterone Treatment on Cardiovascular Outcomes in Men with Hypogonadism: Rationale and Design of the TRAVERSE Study.

  2021cites this paper
• Sexual Dysfunction Among Patients With Chronic Kidney Disease.

  2021cites this paper
• Long‐term testosterone undecanoate treatment in the elderly testosterone deficient male: An observational cohort study

  2021cites this paper
• Testosterone Therapy: Increase in Hematocrit is Associated with Decreased Mortality

  2021cites this paper
• Testosterone and Prostate Effects

  2021cites this paper
• Testosterone and Disordered Sleep

  2021cites this paper
• Diagnosis and management of erectile dysfunction

  2021cites this paper
• Erythrocytosis in Patients on Testosterone Therapy

  2021cites this paper
• Testosterone Level and Coronary Artery Disease in Iranian Men; a Systematic Review

  2021cites this paper
• Optimizing the Diagnostic Accuracy and Treatment Decisions in Men with Testosterone Deficiency.

  2021cites this paper
• Anabolic-Androgenic Steroid Use in Sports, Health, and Society

  2021cites this paper
• Compliance with Testosterone Replacement Therapy in Patients with Testosterone Deficiency Syndrome: A 10-Year Observational Study in Korea

  2021cites this paper
• INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"

  2021cites this paper
• Advances in stem cell research for the treatment of primary hypogonadism

  2021cites this paper
• European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction.

  2021cites this paper
• Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications.

  2021cites this paper
• Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men

  2021cites this paper
• International clinical practice guidelines for gender minority/trans people: systematic review and quality assessment

  2021cites this paper
• Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years

  2021cites this paper
• Mental Health of Men in Later Life

  2021cites this paper
• Testosteronmangel im Alter – was ist zu tun?

  2021cites this paper
• Late-onset hypogonadism: clinical evidence, biological aspects and evolutionary considerations.

  2021cites this paper
• Design and Implementation of the Modern Men’s Health Center: A Multidisciplinary Approach

  2021cites this paper
• Canadian Urological Association clinical practice guideline on testosterone deficiency in men: Evidence-based Q&A.

  2021cites this paper
• Hypogonadism and cancer survivorship

  2020cites this paper
• Current National and International Guidelines for the Management of Male Hypogonadism: Helping Clinicians to Navigate Variation in Diagnostic Criteria and Treatment Recommendations

  2020cites this paper
• Effects of Testosterone on Serum Concentrations, Fat-free Mass, and Physical Performance by Population: A Meta-analysis.

  2020cites this paper
• Controversies in Testosterone Therapy.

  2020cites this paper
• Oncological safety and functional outcomes of testosterone replacement therapy in symptomatic adult-onset hypogonadal prostate cancer patients following robot-assisted radical prostatectomy

  2020cites this paper
• A cross-sectional comparison of secondary polycythemia in testosterone-deficient men treated with nasal testosterone gel vs. intramuscular testosterone cypionate.

  2020cites this paper
• Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?

  2020cites this paper
• Testosterone therapy: where do the latest guidelines agree and differ?

  2020cites this paper
• Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system

  2020cites this paper
• Urologic Endocrinology

  2020cites this paper
• Morbidity in Klinefelter syndrome and the effect of testosterone treatment

  2020cites this paper
• Hepcidin is not essential for mediating testosterone's effects on erythropoiesis

  2020cites this paper